13F HOLDINGS REPORT
TCG Crossover Management, LLC
Quarter ended Q3 2025 · Filed November 17, 2025 · Accession 0001214659-25-016751
Total Value
$2.03B
Positions
40
Other Managers
0
Confidential Omitted
No
Holdings (40)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | ABIVAX SA AMERICAN DEPOSITARY SHARES | AAVXF | 7,111,596 | $603.8M | 29.70% |
| 2 | CG ONCOLOGY INC | CGON | 3,670,206 | $147.8M | 7.27% |
| 3 | COGENT BIOSCIENCES INC | COGT | 6,798,162 | $97.6M | 4.80% |
| 4 | AMYLYX PHARMACEUTICALS INC | AMLX | 6,243,812 | $84.9M | 4.17% |
| 5 | CENTESSA PHARMACEUTICALS PLC | CNTA | 3,136,480 | $76.1M | 3.74% |
| 6 | TANGO THERAPEUTICS INC | TNGX | 8,536,196 | $71.7M | 3.53% |
| 7 | OCULAR THERAPEUTIX INC | OCUL | 6,117,232 | $71.5M | 3.52% |
| 8 | DIANTHUS THERAPEUTICS INC | DNTH | 1,676,624 | $66.0M | 3.25% |
| 9 | TOURMALINE BIO INC | 89157D105 | 1,311,783 | $62.7M | 3.09% |
| 10 | DYNE THERAPEUTICS INC | DYN | 4,615,144 | $58.4M | 2.87% |
| 11 | AGIOS PHARMACEUTICALS INC | AGIO | 1,430,041 | $57.4M | 2.82% |
| 12 | EYEPOINT PHARMACEUTICALS INC | EYPT | 3,572,335 | $50.9M | 2.50% |
| 13 | FULCRUM THERAPEUTICS INC | FULC | 5,250,000 | $48.3M | 2.38% |
| 14 | SAVARA INC | SVRA | 12,362,205 | $44.1M | 2.17% |
| 15 | RAPT THERAPEUTICS INC | 75382E208 | 1,636,275 | $42.2M | 2.08% |
| 16 | TYRA BIOSCIENCES INC | TYRA | 2,898,103 | $40.5M | 1.99% |
| 17 | UPSTREAM BIO INC | UPB | 2,117,103 | $39.8M | 1.96% |
| 18 | LIQUIDIA TECHNOLOGIES INC | LQDA | 1,710,084 | $38.9M | 1.91% |
| 19 | DISC MEDICINE INC | IRON | 465,257 | $30.7M | 1.51% |
| 20 | STRUCTURE THERAPEUTICS INC | GPCR | 1,063,000 | $29.8M | 1.46% |
| 21 | XENCOR INC | XNCR | 2,452,138 | $28.8M | 1.41% |
| 22 | LB PHARMACEUTICALS INC | LBRX | 1,745,016 | $27.6M | 1.36% |
| 23 | REVOLUTION MEDICINES INC | RVMDW | 436,473 | $20.4M | 1.00% |
| 24 | ASTRIA THERAPEUTICS INC | 04635X102 | 2,761,861 | $20.1M | 0.99% |
| 25 | KORRO BIO INC | KRRO | 416,301 | $19.9M | 0.98% |
| 26 | KODIAK SCIENCES INC | KOD | 1,145,538 | $18.8M | 0.92% |
| 27 | SPYRE THERAPEUTICS INC | SYRE | 1,100,582 | $18.4M | 0.91% |
| 28 | SILENCE THERAPEUTICS PLC | SLNCF | 3,033,560 | $15.7M | 0.77% |
| 29 | UROGEN PHARMA LTD | URGN | 717,347 | $14.3M | 0.70% |
| 30 | ARVINAS HOLDING CO LLC | ARVN | 1,617,365 | $13.8M | 0.68% |
| 31 | MONOPAR THERAPEUTICS INC | MNPR | 153,000 | $12.5M | 0.61% |
| 32 | MBX BIOSCIENCES INC | MBX | 650,000 | $11.4M | 0.56% |
| 33 | VISTAGEN THERAPEUTICS INC | VTGN | 2,676,580 | $9.5M | 0.47% |
| 34 | RELAY THERAPEUTICS INC | RLAY | 1,810,351 | $9.5M | 0.46% |
| 35 | ADVERUM BIOTECHNOLOGIES INC | 00773U207 | 1,668,174 | $7.6M | 0.37% |
| 36 | AVALO THERAPEUTICS INC | AVTX | 483,000 | $6.1M | 0.30% |
| 37 | ADC THERAPEUTICS SA | ADCT | 1,390,175 | $5.6M | 0.27% |
| 38 | PEPGEN INC | PEPG | 1,200,000 | $5.5M | 0.27% |
| 39 | ENTRADA THERAPEUTICS INC | TRDA | 584,955 | $3.4M | 0.17% |
| 40 | VENTYX BIOSCIENCES INC | 92332V107 | 316,195 | $983,366 | 0.05% |